Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 11, 2002

View Archived Issues

SciClone updates progress of Zadaxin

Pharmacological profile of LASSBio-341 suggests potential in asthma Rx

Antitumor prodrug with favorable pharmaceutical/pharmacokinetic properties heads for human testing

Neuroprotection with erythropoietin results in significant benefit in stroke patients

Dexamethasone protects against cerebral ischemia by an eNOS-dependent mechanism

Natural tomato extract under investigation for use in cancer

InKine reports on progress during the fourth quarter of 2001

Biomira initiates phase II trial of Theratope vaccine in metastatic colorectal cancer

Milestones in Genome Therapeutics/Schering-Plough asthma alliance

Transdermal TB diagnostic continues to give positive results in late-stage clinical trials

BioMarin to acquire Glyko Biomedical

Approval for Metvix PDT in New Zealand

Adenoviral gene transfer of SOD may be useful for preventing vasospasm

Achillion to use ViroLogic's assays to evaluate antiviral product candidates

Patient enrollment completed in phase III trial of MethyPatch in ADHD

Negative response obtained from Health Canada for Pennsaid Topical Solution

Viread approved in E.U. for treatment of HIV

FDA recommends two phase III trials for Liprostin

Selective inhibitor of excessive glial activation discovered by U.S.-French team

Neurogen claims GABA-A receptor ligands for anxiety, etc.

Recent patent covers cephalosporins particularly useful against MRSA

AstraZeneca identifies benzimidazoles for H. pylori infections

Method of treating insomnia using gabapentin analogues

Merck KGaA discloses compounds with PDE5-inhibitory activity

Arixtra introduced in the U.S. for preventing thromboembolic events following surgery

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...